Communications Biology (Oct 2023)

The ATF2/miR-3913-5p/CREB5 axis is involved in the cell proliferation and metastasis of colorectal cancer

  • Weiyu Dai,
  • Linjie Hong,
  • Wushuang Xiao,
  • Luyu Zhang,
  • Weihong Sha,
  • Zhen Yu,
  • Xuehua Liu,
  • Side Liu,
  • Yizhi Xiao,
  • Ping Yang,
  • Ying Peng,
  • Jieming Zhang,
  • Jianjiao Lin,
  • Xiaosheng Wu,
  • Weimei Tang,
  • Zhizhao Lin,
  • Li Xiang,
  • Jiaying Li,
  • Miaomiao Pei,
  • Jide Wang

DOI
https://doi.org/10.1038/s42003-023-05405-w
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Various miRNAs have been shown to participate in the tumor progression and development of colorectal cancer (CRC). However, the role of miR-3913-5p in CRC are yet to be clearly defined. In the present study, we determine that miR-3913-5p is downregulated in CRC cell lines and CRC tissues. Exogenous miR-3913-5p expression weakens the CRC cells growth, migration and invasion. Mechanistically, miR-3913-5p directly targets the 3’UTR of CREB5. Overexpression of CREB5 reverses the suppression of CRC cells proliferation, migration and invasion induced by miR-3913-5p. Furthermore, ATF2 negatively regulates the transcription of miR-3913-5p by binding to its promoter. CREB5 can cooperate with ATF2. CREB5 is required for ATF2 in regulating miR-3913-5p. Finally, inverse correlations can be found between the expressions of miR-3913-5p and CREB5 or ATF2 in CRC tissues. Thus, a plausible mechanism of ATF2/miR-3913-5p/CREB5 axis regulating CRC progression is elucidated. Our findings suggest that miR-3913-5p functions as a tumor suppressor in CRC. ATF2/miR-3913-5p/CREB5 axis might be a potential therapeutic target against CRC progression.